Advertisement

Methadone Maintenance Treatment for Harm Reduction Approach to Heroin Addiction

  • M. J. Kreek
Conference paper

Abstract

It is estimated that there are now over one million persons who have used heroin regularly in the United States and possibly two million that have used heroin at some time. Of these, it is estimated that at least 500,000 are “hard-core” heroin addicts, defined as users of multiple, regular self-administered doses of short-acting opiates such as heroin each day for one year or more, with the development of tolerance, physical dependence and drug seeking behavior, thus, addiction. (42,43,54)

Keywords

Drug Dependence Methadone Maintenance Treatment Methadone Maintenance Hepatitis Delta Virus Heroin Addict 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Albeck, H., Woodfield, S., Kreek, M.J.: Quantitative and pharmacokinetic analysis of naloxone in plasma using high performance liquid chromatography with electrochemical detection and solid phase extrac tion. J. Chromatog. 488: 435–445, 1989.CrossRefGoogle Scholar
  2. 2.
    Albeck, H., Woodfield, S., Wahlstrom, A., Kreek, M.J.: Naloxone pharmacokinetics in man following an intravenous dose. In: Problems of Drug Dependence. 1990: Proceedings of the 52nd Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD, in press 1991.Google Scholar
  3. 3.
    Bodner, G., Albeck, H., Soda, K.M., Kreek, M.J.: Modulation of natural killer cell activity: Possible role of hypothalamic-pituitary-adrenal hormones. In: New Leads in Opioid Research. Eds. Van Ree, J.M., Mulder, A.H., Wiegant, V.M., and Van Wimersma Greulanus, T.B., Excerpta Medica, Amsterdam 330–331, 1990.Google Scholar
  4. 4.
    Bodner, G., Soda, K.M., Kennedy, J., Kreek, M.J.: Modulation of NK Activity: role of neuroendocrine status. In: Problems of Drug Dependence. 1990: Proceedings of the 52nd Annual Scientific Meeting of the Committee on Problems of Dru_ Dependence. Harris, L.S. ed., NIDA Research Monograph Series. Rockville, MD, in press 1991.Google Scholar
  5. 5.
    Bowen, D.V., Smit, A.L.C. and Kreek, M.J.: Fecal excretion of methadone and its metabolites in man: Application of GC-MS. In: Advances in Mass Spectrometry, N.R. Daly, ed., Philadelphia, PA: Heyden & Son, Inc., 7B:1634–1639, 1978.Google Scholar
  6. 6.
    Culpepper-Morgan, J.A., Holt, P.R., Kreek, M.J.: Colonic opiate receptors change with age: Preliminary data. In: Problems of Drug Dependence, 1987: Proceedings of the 49th Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD DHHS Publications No. (ADM)88–1564 81:267, 1988.Google Scholar
  7. 7.
    Culpepper-Morgan, J., Kreek, M.J., Holt, P.R., La Roche, D., Zhang, J., O’Bryan, L.: Orally administered kappa as well as mu opiate delay gastrointestinal transit time in the guinea pig. Life Sciences, 42: 2073–2077, 1988.PubMedCrossRefGoogle Scholar
  8. 8.
    Cushman, P. and Kreek, M.J.: Some endocrinologic observations in narcotic addicts. In: Narcotic and the Hypothalamus, E. Zimmerman and R. George, eds., New York, NY: Raven Press, 161–173, 1974.Google Scholar
  9. 9.
    Cushman, P., Kreek, M.J. and Gordis, E.: Ethanol and methadone in man: A possible drug interaction. Drug and Alc. Dep., 3: 35–42, 1978.CrossRefGoogle Scholar
  10. 10.
    Des Jarlais, D.C., Friedman, S.R., Novick, D.M., Sotheran, J.L., Thomas, P., Yancovitz, S.R., Mildvan, D., Weber, J. Kreek, M.J., Maslansky, R., Bartelme, S.,Spira, T. Marmor, M. HIV I Infection among intravenous drug users in Manhattan, New York City 1977 to 1987. JAMA 261: 1008–1012, 1989.Google Scholar
  11. 11.
    Des Jarlais, D.C., Marmor, M., Cohen, H., Yancovitz, S., Garber, J., Friedman, S., Kreek, M.J., Miescher, A., Khuri, E., Friedman, S.M., Rothenberg, R., Echenberg, D., O’Malley, P.O., Braff, E., Chin, J., Burtenol, P., Sikes, R.K.: Antibodies to a retrovirus etiologically associated with Acquired Immunodeficiency Syndrome (AIDS) in populations with increased incidences of the syndrome. Morbidity and Mortality Weekly Report, 33: 377–379, 1984.Google Scholar
  12. 12.
    Dole, V.P. and Kreek, M.J.: Methadone plasma level: Sustained by a reservoir of drug in tissue. Proc. Natl. Acad. Sci., 70: 10, 1973.PubMedCrossRefGoogle Scholar
  13. 13.
    Dole, V.P., Nyswander, M.E. and Kreek, M.J.: Narcotic blockade. Arch. Intern. Med., 118: 304–309, 1966.PubMedCrossRefGoogle Scholar
  14. 14.
    Hachey, D.L., Kreek, M.J. and Mattson, D.H.: Quantitative analysis of methadone in biological fluids using deuterium-labeled methadone and GLC-chemical-ionization mass spectrometry. J. Pharm. Sci., 66: 1579–1582, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Hachey, D.L., Mattson, D.H. and Kreek, M.J.: Quantitation of methadone in biological fluids using deuterium labeled internal standards. In: Proceedings of the Second International Conference on Stable Isotopes, E.R. Klein and P.D. Klein, eds., ERDA-CONF-751027, Springfield, VA: National Technical Information Source, U.S. Dept. of Commerce, 518–523, 1976.Google Scholar
  16. 16.
    Hachey, D.L., Nakamura, K., Kreek, M.J. and Klein, P.D.: Analytical techniques for using multiple, simultaneous stable isotopic tracers. In: Stable Isotopes, H.L. Schmidt, H. Forstel and K. Heinzinger, eds., Amsterdam: Elsevier Scientific Publishing Company, 235–239, 1982.Google Scholar
  17. 17.
    Hahn, E.F., Lahita, R., Kreek, M.J., Duma, C., Inturrisi, C.E.: Naloxone radioimmunoassay: an improved antiserum. J. Pharm. Pharmacol., 35:, 833–836, 1983.Google Scholar
  18. 18.
    Kaufmann, C.A., Kreek, M.J., Karoum, F. and Chuang, L.W.: Depression during methadone withdrawal: No role for betaphenylethylamine. Drug and Alcohol Dependence, 13: 21–29, 1984.PubMedCrossRefGoogle Scholar
  19. 19.
    Kaufmann, C.A., Kreek, M.J., Raghunath, J., Arns, P.: Methadone, monoamine oxidase and depression: Opioid dist-ribution and acute effects on enzyme activity.Biol. Psychiatry, 18: 1007–1021, 1983.Google Scholar
  20. 20.
    Kennedy, J.A., Hartman, N., Sbriglio, R., Khuri, E., Kreek, M.J.: Metyrapone-induced withdrawal symptoms. Brit J Addict 85: 1133–1140, 1990.CrossRefGoogle Scholar
  21. 21.
    Klein, P.D., Hachey, D.L., Kreek, M.J. and Schoeller, D.A.: Stable isotopes: Essential tools in biological and medical research. In: Stable Isotopes: Applications in Pharmacology. Toxicology and Clinical Research, T.A. Baillie, ed., Baltimore, MD: University Park Press, 3–14, 1978.Google Scholar
  22. 22.
    Kosten, T.R., Kreek, M.J., Raghunath, J., Kleber, H.D.: A preliminary study of beta-endorphin during chronic naltrexone maintenance treatment in ex-opiate addicts. Life Sciences 39: 55–59, 1986a.PubMedCrossRefGoogle Scholar
  23. 23.
    Kosten, T.R., Kreek, M.J., Raghunath, J., Kleber, H.D.: Cortisol levels during chronic naltrexone maintenance treatment in ex-opiate addicts. Biological Psychiatry. 21: 217–220, 1986b.PubMedCrossRefGoogle Scholar
  24. 24.
    Kosten, T.R., Kreek, M.J., Swift, C., Carney M.K., Ferdinands, L.: Beta-endorphin levels in CSF during methadone maintenance. Life Sciences, 41: 1071–1076, 1987.PubMedCrossRefGoogle Scholar
  25. 25.
    Kreek, M.J.: Medical safety, side effects and toxicity of methadone. Proceedings of the Fourth National Conference on Methadone Treatment, NAPAN-NIMH, 171–174, 1972.Google Scholar
  26. 26.
    Kreek, M.J.: Medical safety and side effects of methadone in tolerant individuals. J. Amer. Med. Assn., 223: 665–668, 1973a.CrossRefGoogle Scholar
  27. 27.
    Kreek, M.J.: Physiological implications of methadone treatment. In: Methadone Treatment Manual, U.S. Dept. of Justice (USGPO) #2700–00227, Washington, D.C.: 85–91, 1973b.Google Scholar
  28. 28.
    Kreek, M.J.: Plasma and urine levels of methadone. N.Y. State J. Med., 73: 2773–2777, 1973c.Google Scholar
  29. 29.
    Kreek, M.J.: Pharmacologie modalities of therapy: Methadone maintenance and the use of narcotic antagonists. In: Heroin dependency: Medical, economic and social aspects, B. Stimmel, ed., New York, NY: Stratton Intercontinental Medical Book Corp., 232–290, 1975.Google Scholar
  30. 30.
    Kreek, M.J.: The role of qualitative and quantitative analysis of drugs and their metabolites in maternal–neonatal studies. In: National Institute on Drug Abuse Symposium on Comprehensive Health Care for Addicted Families and Their Children, Services Research Report (USGPO), #017–024–00598–3, Washington, DC:67–73, 1977.Google Scholar
  31. 31.
    Kreek, M.J.: Medical complications in methadone patients. Ann. N.Y. Acad. Sci., 311: 110–134, 1978a.PubMedCrossRefGoogle Scholar
  32. 32.
    Kreek, M.J.: Effects of drugs and alcohol on opiate disposition and action. In: Factors Affecting the Action of Narcotics, M.W. Adler, L. Manara and R. Saminin, eds., New York, NY: Raven Press, 717–739, 1978b.Google Scholar
  33. 33.
    Kreek, M.J.: Methadone disposition during the perinatal period in humans. Pharmac. Biochem. Behay., 11, Suppl.: 7–13, 1979a.Google Scholar
  34. 34.
    Kreek, M.J.: Methadone in treatment: Physiological and pharmacological issues. In: Handbook on Drug Abuse, R.L. Dupont, A. Goldstein and J. O’Connell, eds., NIDA-ADAMHA-DEW-ODAP-Executive Office of the President, 57–86, 1979b.Google Scholar
  35. 35.
    Kreek, M.J.: Metabolic interactions between opiates and alcohol. Ann. N.Y. Acad.Sci., 362: 36–49, 1981.PubMedCrossRefGoogle Scholar
  36. 36.
    Kreek, M.J.: Disposition of narcotics in the perinatal period. In: Publication of AMERSA and The Career Teacher Program in Alcohol and Drug Abuse, 3: 7–10, 1981–82.Google Scholar
  37. 37.
    Kreek, M.J.: Opioíd disposition and effects during chronic exposure in the perinatal period in man. In: Journal of Addictive Diseases, B. Stimmel, ed., New York, NY: The Haworth Press, Inc., 1:21–53, 1982.Google Scholar
  38. 38.
    Kreek, M.J.: Physiological and Pharmacological tiveness of methadone. In: Research in Narcotic Addiction: State of the Art, J.R. B.S. Brown, and D. Czechowicz, eds.,National Abuse Monograph, DHHS Pub. # (ADM) 83–1281, 95–114, 1983.Google Scholar
  39. 39.
    Kreek, M.J.: Opioid interactions with alcohol. Journal of Addictive Diseases New York, NY: The Haworth Press, 3: 35–46, 1984.Google Scholar
  40. 40.
    Kreek, M.J.: Drug interactions with methadone in humans. In: Strategies for Research on the Interactions of Drugs of Abuse, NIDA Research Monograph 68 Braude, M.C. and Ginzburg, H.M., eds., Rockville, MD., 68:193–225, 1986a.Google Scholar
  41. 41.
    Kreek, M.J.: Exogenous Opioids: Drug-Disease Interactions, Advances in Pain Research and Therapy, eds. Foley, K.M., Inturrisi, C.E., New York, NY: Raven Press, 8: 201–210, 1986b.Google Scholar
  42. 42.
    Kreek, M.J.: Multiple Drug Abuse Patterns and Medical Consequences. In: Psychopharmacology: The Third Generation of Progress. Meltzer, H.Y., ed. Raven Press, New York, NY 1597–1604, 1987a.Google Scholar
  43. 43.
    Kreek, M.J.: Tolerance and Dependence - Implications for the pharmacological treatment of addiction. In: Problems of Drug Dependence, 1986; Proceedings of the 48th Annual Scientific Meeting of The Committee on Problems of Drug Dependence. Harris, L.S., ed., NIDA Research Monograph Series, Rockville, MD, DHHS Publication No.(ADM) 87–1508 76:53–61, 1987b.Google Scholar
  44. 44.
    Kreek, M.J.: Opiate-ethanol interactions: Implications for the biological basis and treatment of combined addictive diseases. In: Problems of Drug Dependence. 1987: Proceedings of the 49th Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S., ed. NIDA Research Monograph Series Rockville, MD DHHS Publication No. (ADM)88–1564 81:428–439, 1988.Google Scholar
  45. 45.
    Kreek, M.J.: Immunological approaches to clinical issues in drug abuse. In: Problems of Drug Dependence, 1988: Proceedings of the 50th Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD DHHS Publication No. (ADM)89–1605 90:77–86, 1989.Google Scholar
  46. 46.
    Kreek, M.J.: Drug interactions in humans related to drug abuse and its Treatment. Modern Methods in Pharmacology 6: 265–282, 1990a.Google Scholar
  47. 47.
    Kreek, M.J.: Historical and medical aspects of methadone maintenance treatment: Effectiveness in treatment of heroin addiction and implications of such treatment in the setting of the AIDS epidemic. Evaluation of Different Programmes for Treatment of Drug Addicts Adamsson, C., Jansson, B., Rydberg, U., Westrin, C., (Eds.), Medicinska Forskningsradet, Stockholm, Sweden, 61–76, 1990b.Google Scholar
  48. 48.
    Kreek, M.J.: Methadone maintenance treatment for heroin addiction. The Effectiveness of Drug Abuse Treatment: Dutch and American Perspectives Platt, J.J., Kaplan, C.D., McKim, P.J., (Eds.), Malabar, Florida: Krieger Publishing Co. 275–293, 1990c.Google Scholar
  49. 49.
    Kreek, M.J.: HIV infection and parenteral drug abuse: ethical issues in diagnosis, treatment, research and the maintenance of confidentiality. In: Proceedings of the Third International Congress on Ethics in Medicine–Nobel Conference Series. P. Allebeck, B. Jansson, eds. Raven Press, New York, NY 181–187, 1990d.Google Scholar
  50. 50.
    Kreek, M.J.: Immune function in heroin addicts and former heroin addicts in treatment: pre/post AIDS epidemic. Current Chemical and Pharmacological Advances on Drugs of Abuse Which Alter Immune Function and Their Impact Upon HIV Infection: Pham, P.T.K., and Rice, K., eds. NIDA Research Monograph Series, Rockville, MD 96:192–219, 1990e.Google Scholar
  51. 51.
    Kreek, M.J.: Multiple Drug Abuse Patterns: Recent trends and associated medical consequences. Advances in Substance Abuse: Behavioral and Biological Research, Volume 4, Jessica Kingsley Publishers Ltd., London, England. In press 1990f.Google Scholar
  52. 52.
    Kreek, M.J.: Neuroendocrine (HPA) and Gastrointestinal Effects of Opiate Antagonists: Possible Therapeutic Application. In: Problems of Drug Dependence 1990: Proceedings of the 52nd Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series. Rockville, MD, in press 1991a.Google Scholar
  53. 53.
    Kreek, M.J.: Immunological Function in Active Heroin Addicts and Methadone Maintained Former Addicts: Observations and Possible Mechanisms. In: Problems of Drug Dependence, 1990; Proceedings of the 52nd Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD, in press 1991b.Google Scholar
  54. 54.
    Kreek, M.J.: Using methadone effectively: achieving goals by application of laboratory, clinical, and evaluation research any by development of innovative programs. Improving Drug Abuse Treatment: Pickens, R., Leukefeld, C., Schuster, R. eds. NIDA Research Monograph Series Rockville, MD in press, 1991c.Google Scholar
  55. 55.
    Kreek, M.J., Bencsath, F.A., Fanizza, A. and Field, F.H.: Effects of liver disease on fecal excretion of methadone and its unconjugated metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry. Biomed Mass Spectrm., 10: 544–549, 1983.CrossRefGoogle Scholar
  56. 56.
    Kreek, M.J., Bencsath, F.A. and Field, F.H.: Effects of liver disease on urinary excretion of methadone and metabolites in maintenance patients: Quantitation by direct probe chemical ionization mass spectrometry. Biomedical Mass Spectrometry, 7: 385–395, 1980.PubMedCrossRefGoogle Scholar
  57. 57.
    Kreek, M.J., Brown, L.T., Bernstein, W.J. and Harte, E.H.: Estrogen treatment alters narcotic disposition in the rat. In: Proceedings of the 1979 International Narcotic Research Conference, E.L. Way, ed., New York: Pergamon Press, 405–407, 1980.Google Scholar
  58. 58.
    Kreek, M.J., Des Jarlais, D.C., Trepo, C.L., Novick, D.M., Abdul-Quader, A., Raghunath, J.: Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without aids. J Infect Dis, 162: 538–541, 1990.PubMedCrossRefGoogle Scholar
  59. 59.
    Kreek, M.J., Dodes, L., Kane, S., Knobler, J. and Martin, R.: Long-term methadone maintenance therapy: Effects on liver function. Ann. Intern. Med., 77: 598–602, 1972.PubMedGoogle Scholar
  60. 60.
    Kreek, M.J., Garfield, J.W., Gutjahr, C.L. and Giusti, L.M.: Rifampin-induced methadone withdrawal. New Engl. J. Med., 294: 1104–1106, 1976.Google Scholar
  61. 61.
    Kreek, M.J., Gutjahr, C.L., Bowen, D.V. and Field, F.H.: Fecal excretion of methadone and its metabolites: A major pathway of elimination in man. In: Critical Concerns in the Field of Drug Abuse: Proceedings of the Third National Drug Abuse Conference, A. Schecter, H. Alksne and E. Kaufman, eds., New York, NY: Marcel Dekker, Inc., 1206–1210, 1978.Google Scholar
  62. 62.
    Kreek, M.J., Gutjahr, C.L., Garfield, J.W., Bowen, D.V. and Field, F.H.: Drug interactions with methadone. Ann. N.Y. Acad. Sci., 281: 350–370, 1976.PubMedCrossRefGoogle Scholar
  63. 63.
    Kreek, M.J., Hachey, D.L. and Klein, P.D.: Stereoselective disposition of methadone in man. Life Sci., 24: 925–932, 1979.PubMedCrossRefGoogle Scholar
  64. 64.
    Kreek, M.J. and Hartman, N.: Chronic use of opioids and antipsychotic drugs: Side effects, effects on endogenous opioids and toxicity. Ann. N.Y. Acad. Sci., 398: 151–172, 1982.PubMedCrossRefGoogle Scholar
  65. 65.
    Kreek, M.J., Kalisman, M., Irwin, M., Jaffery, N.F. and Scheflan, M.: Biliary secretion of methadone and methadone metabolites in man. Res. Comm. Chem. Path. Pharmacol., 29: 67–78, 1980.Google Scholar
  66. 66.
    Kreek, M.J., Khuri, E., Fahey, L., Miescher, A., Arns, P., Spagnoli, D., Craig, J., Millman, R., Harte, E.: Long term follow-up studies of the medical status of adolescent former heroin addicts in chronic methadone maintenance treatment: Liver disease and immune status. In: Problems of Drug Dependence, 1985; Proceedings of the 47th Annual Scientific Meeting of The Committee on Problem of Drug Dependence. Harris, L.S., ed., NIDA Research Monograph Series Rockville, MD., DHHS Publication No.(ADM) 86–1448 67: 307–309, 1986.Google Scholar
  67. 67.
    Kreek, M.J., Khuri, E., Flomenberg, N., Albeck, H., Ochshorn, M.: Immune status of unselected methadone maintained former heroin addicts. International Narcotics Research Conference 1989 (INRC), Quirion, R., Jhamandas, K., Gianoulakis, C., eds., Alan R. Liss, Inc., New York, NY, 445–448, 1989.Google Scholar
  68. 68.
    Kreek, M.J., Khuri, E. and Joseph, H.: A new “heroin epidemic” ? Ann. Intern. Med., 83: 420–421, 1975.PubMedGoogle Scholar
  69. 69.
    Kreek, M.J., Oratz, M. and Rothschild, M.A.: Hepatic extraction of long-and short-acting narcotics in the isolated perfused rabbit liver. Gastroenterology, 75: 88–94, 1978.PubMedGoogle Scholar
  70. 70.
    Kreek, M.J., Raghunath, J., Plevy, S., Hamer, D., Schneider, B., and Hartman, N.: ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides, 5: 277–278, 1984.PubMedCrossRefGoogle Scholar
  71. 71.
    Kreek, M.J., Rothschild, M.A., Oratz, M., Mongelli, J. and Handley, A.C.: Acute effects of ethanol on hepatic uptake and distribution of narcotics in the isolated perfused rabbit liver. Hepatology, 1: 419–423, 1981.PubMedCrossRefGoogle Scholar
  72. 72.
    Kreek, M.J., Schecter, A.J., Gutjahr, C.L. and Hecht, M.: Methadone use in patients with chronic renal disease. Drug and Alcohol Depend., 5: 197–205, 1980.CrossRefGoogle Scholar
  73. 73.
    Kreek, M.J., Wardlaw, S.L., Friedman, J., Schneider, B. and Frantz, A.G.: Effects of chronic exogenous opioid administration on levels of one endogenous opioíd (beta-endorphin) in man. Advances in Endogenous and Exogenous Opioids, Simon E. and Takagi, H. eds., Tokyo, Japan: Kodansha Ltd. Publishers, 364366, 1981.Google Scholar
  74. 74.
    Kreek, M.J., Wardlaw, S.L., Hartman, N., Raghunath, J., Friedman, J., Schneider, B. and Frantz, A.G.: Circadian rhythms and levels of beta-endorphin, ACTH, and cortisol during chronic methadone maintenance treatment in humans. Life Sciences, Sup. I, 33: 409–411, 1983.Google Scholar
  75. 75.
    Nakamura, K., Hachey, D.L., Kreek, M.J., Irving, C.S. and Klein, P.D.: Quantitation of methadone enantiomers in humans using stable isotope-labeled 2H3,2H5, 2H8 methadone. J. Pharm. Sci., 71: 39–43, 1982.Google Scholar
  76. 76.
    Nakamura, K., Kreek, M.J., Hachey, D.L., Irving, C.S. and Klein, P.D.: Studies on disposition of dl-methadone in former heroin addicts by the multiple deuterium labeling method. Proceedings of the Japanese Society for Medical Mass Spectrometry, 6: 119–124, 1981.Google Scholar
  77. 77.
    Novick, D.M., Des Jarlais, D.C., Kreek, M.J., Spira, T.J., Friedman, S.R., Gelb, A.M., Stenger, R.J., Schable, C.A., Kalyanaraman, V.S.: The specificity of antibody tests for human immunodeficiency virus in alcohol and parenteral drug abusers with chronic liver disease. Alcoholism: Clinical and Experimental Research 12, 687–690, 1988.CrossRefGoogle Scholar
  78. 78.
    Novick, D.M., Farci, P. Croxson, S.T., Taylor, M.B., Schneebaum, C.W., Lai, E.M., Bach, N. Senie, R.T., Gelb, A.M., Kreek, M.J.: Hepatitis delta virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive. J. Infect. Dis., 158: 795–803, 1988.PubMedCrossRefGoogle Scholar
  79. 79.
    Novick, D.M., Khan, I., Kreek, M.J.: Acquired immunodeficiency syndrome and infection with hepatitis viruses in individuals abusing drugs by injection. United Nations Bulletin on Narcotics, 38: 15–25, 1986.Google Scholar
  80. 80.
    Novick, D.M., Kreek, M.J., Arns, P.A. Lau, L.L., Yancovitz, S.R., and Gelb, A.M.: Effects of severe alcoholic liver disease on the disposition of methadone in maintenance patients. Alcoholism: Clin. Exp. Res., 9: 349–354, 1985.CrossRefGoogle Scholar
  81. 81.
    Novick, D., Kreek, M.J., Des Jarlais, D., Spira, T.J., Khuri, E.T., Raghunath, J., Kalyanaraman, V.S., Gelb, A.M., and Miescher, A.: Antibody to LAV, the putative agent of AIDS, in parenteral drug abusers and methadone-maintained patients: Abstract of clinical research findings: Therapeutic, historical, and ethical aspects. In: Problems of Drug Dependence, 1985: Proceedings of the 47th Annual Scientific Meeting of The Committee on Problems of Drug Dependence. Harris, L.S., ed.,NIDA Research Monograph Series., Rockville, MD., DHHS Publication No. (ADM)86–1448 67:318–320, 1986.Google Scholar
  82. 82.
    Novick, M., Kreek, M.J., Fanizza, A.M., Yancovitz, S.R., Gelb, A.M. and Stenger, R.J.: Methadone disposition in patients with chronic liver disease. Clin.Pharmacol. Ther., 30: 353–362, 1981.PubMedCrossRefGoogle Scholar
  83. 83.
    Novick, D.M., Ochshorn, M., Ghali, V., Croxson, T.S., Mercer, W.D., Chiorazzi, N., Kreek, M.J.: Natural Killer Cell Activity and Lymphocyte Subsets in Parenteral Heroin Abusers and Long-term Methadone Maintenance Patients. J. Pharm Exper Ther. 250: 606–610, 1989.Google Scholar
  84. 84.
    Novick, D.$4., Ochshorn, M., Kreek, M.J.: In vivo and in vitro studies of opiates and cellular immunity in narcotic addicts. In: Drugs of Abuse, Immunity and Immunodeficiency. Friedman, Herman, eds., Plenum Press, New York. In press 1991.Google Scholar
  85. 85.
    Novick, D.M., Trigg, H.L., Des Jarlais, D.C., Friedman, S.R., Vlahov, D., Kreek, M.J.: Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J. Med. Virol. 29: 181–185, 1989.PubMedCrossRefGoogle Scholar
  86. 86.
    Ochshorn, M., Kreek, M.J., Hahn, E.F., Novick, D.M.: High Concentrations of naloxone lower natural killer (NK) activity. In: Problems of Drug Dependence, 1987: Proceedings of the 49th Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD DHHS Publication No. (ADM)88–1564, 81:338, 1988.Google Scholar
  87. 87.
    Ochshorn, M., Kreek, M.J., Khuri, E., Fahey, L., Craig, J., Aldana, M.C., Albeck, H.: Normal and abnormal Natural Killer (NK) activity in methadone maintenance treatment patients. In: Problems of Drug Dependence, 1988: Proceedings of the 50th Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD DHHS Publication No. (ADM) 89–1605, 90:369, 1989.Google Scholar
  88. 88.
    Ochshorn, M., Novick, D.M., Kreek, M.J.: In vitro studies of methadone effect on natural killer (NK) cell activity. Israel J of Med Sci 26: 421–425, 1990.Google Scholar
  89. 89.
    Pond, S.M., Kreek, M.J., Tong, T.G., Raghunath, J.: Benowitz, Altered methadone pharmkokinetics in methadone-maintained pregnant women. J of Pharm. & Exper. Thera., 233: 1–6, 1985.Google Scholar
  90. 90.
    Ragavan, V.V., Wardlaw, S.L., Kreek, M.J., Frantz, A.G.: Effect of chronic naltrexone and methadone administration on brain immunoreactive beta-endorphin in the rat. Neuroendocrinology, 37: 266–268, 1983.PubMedCrossRefGoogle Scholar
  91. 91.
    Rubenstein, R.B., Kreek, M.J., Mbawa, N., Wolff, W.I., Korn, R. and Gutjahr, C.L. and Wolff, W.I.: Human spinal fluid methadone levels. Drug and Alc. Dep., 3: 103–106, 1978.CrossRefGoogle Scholar
  92. 92.
    Stimmel, B. and Kreek, M.J.: Pharmacologic actions of heroin. In: Heroin dependency: Medical, economic and social aspects, B. Stimmel, ed., New York, NY: Stratton Intercontinental Medical Book Corp., 71–87, 1975a.Google Scholar
  93. 93.
    Stimmel, B. and Kreek, M.J.: Dependence, tolerance and withdrawal. In: Heroin dependency: Medical, economic and social aspects, B. Stimmel, ed., New York, NY: Stratton Intercontinental Medical Book Corp., 88–97, 1975b.Google Scholar
  94. 94.
    Tong, T.G., Benowitz, N.L. and Kreek, M.J.: Methadone-disulfiram interaction during methadone maintenance J. Clin. Pharmacol., 20: 506–513, 1980.PubMedGoogle Scholar
  95. 95.
    Tong, T.G., Pond, S.M., Kreek, M.J., Jaffery, N.F. and Benowitz, N.L.: Phenytoin-induced methadone withdrawal. Ann. Intern. Med., 94: 349–351, 1981.PubMedGoogle Scholar
  96. 96.
    Unterwald, E.M., Kreek, M.J.: Alterations in the expression of brain opioid receptors during senescence. In: New Leads in Opioid Research Eds: Van Ree, Mulder, Wiegant and Van Wimersma Greidanus, pgs. 200–201, 1990a.Google Scholar
  97. 97.
    Unterwald, E.M., and Kreek, M.J.: Age-related changes in the expression of brain opioid receptors. Society for Neuroscience Abstracts, 16: 368, 1990b.Google Scholar
  98. 98.
    Unterwald, E.M., Nyberg, F., Terenius, L., Kreek, M.J.: Distribution of opioid peptides in brain and GI tract: Age and species-specific differences. In: Problems of Drug Dependence, 1990: Proceedings of the 52nd Annual Scientific Meeting of the Committee on Problems of Drug Dependence. Harris, L.S. ed., NIDA Research Monograph Series, Rockville, MD DHHS Publication No. (ADM) 91–1753 105:408–409, 1990.Google Scholar
  99. 99.
    Zhang, J.S;, Plevy, S., Albeck, H., Culpepper-Morgan. J., Friedman, J., Kreek, M.J.: Effects of age on distribution of preproenkephalin-like mRNA in the gastrointestinal tract of the guinea pig. Advances in the Biosciences: Proceedings of 1988 INRC meeting 75: 349–350, 1989.Google Scholar
  100. 100.
    Ziring, B., Brown, L. and Kreek, M.J.: Effects of route of administration on methadone disposition in the rat. In: Problems of Drug Dependence, 1980, Proceedings of the 42nd Annual Scientific Meeting of the Committee on Problems of Drug Dependence, L.S. Harris, ed., NIDA Research Monograph Series, Rockville, MD DHHS Publication No. 34:145–151, 1981.Google Scholar
  101. 101.
    Ziring, B.S., Kreek, M.J. and Brown, L.T.: Methadone disposition following oral versus parenteral dose administration in rats during chronic treatment. Drug Alc. Depend., 7: 311–318, 1981.CrossRefGoogle Scholar
  102. 102.
    Ziring, B., Shepperd, S., and Kreek, M.J.: Reversed phase thin-layer chromatography for the separation of betaendorphin, beta-lipotropin and enkephalins. Int. J. Peptide Protein Res., 22: 32–38, 1983.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1991

Authors and Affiliations

  • M. J. Kreek
    • 1
  1. 1.The Rockefeller University NYNew YorkUSA

Personalised recommendations